OS Therapies Inc

OSTX NYSE SEC CIK 1795091

Follow OS Therapies Weekly email: filings, results, news

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP

Net income −$8.6M −90.3% vs same quarter last year

EPS, diluted −$0.20 −5.3% vs same quarter last year

Operating cash flow −$5.5M −134.4% vs same quarter last year

Operating income −$8.6M −77.2% vs same quarter last year

Net income by quarter

−$2.9M

−$3M

−$3.9M

−$4.5M

−$6.9M

−$13.5M

−$10.4M

−$8.6M

Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26

Source: SEC XBRL filings · latest filing

Fiscal years as reported · SEC XBRL filings, US GAAP

Revenue and net income4 fiscal years

Show the numbers

No stories filed under OS Therapies yet - coverage appears here as the news feed clusters it.